This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
All of this is in the face of yet another round of manufacturer cease-and-desist letters to compounding pharmacies and even physicianoffices demanding they cease all compounding, dispensing, and sale of compounded GLP-1s. 5 The difference is significant, as biologics cannot be compounded.
In October 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously voted to update these recommendations, endorsing JYNNEOS for routine use in individuals aged 18 and older with specific risk factors. The CDC estimates that two million individuals in the US are eligible for the mpox vaccination.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Immunity 
29 
Let's personalize your content